OrthoPediatrics (KIDS) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- -$0.23
- Estimate
- -$0.21
- Surprise
- -7.0%
- Score today
- 5.7/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
OrthoPediatrics (KIDS) reported a wider loss than forecast — adjusted EPS of -$0.23 against the -$0.21 estimate (a 7.0% shortfall).
Coverage in the report window
- BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $30 — benzinga, 2026-10-28
- OrthoPediatrics Q3 2026 Earnings Call Transcript — benzinga, 2026-10-27
- OrthoPediatrics Announces FDA Clearance of Pediatric Nailing Platform | Femur Retrograde Nail System — fiscal.ai, 2026-10-27
Where TrendMatrix's rating stands now
TrendMatrix currently rates KIDS Sell at 5.7/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's -7.0% surprise compares with a +3.7% four-quarter average.
What argues against it
- Quality below floor (4.0 < 4.0)
- Reward/Risk 1.0:1 at current price — below 1.5:1 minimum
- Insider activity: 7.52%=extreme
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $23.82
- Price target
- $26.32
- Stop
- $22.18
- Upside to target
- +10.5%
- Reward-to-risk
- 1.0:1
Risk check: trading volume is running 1.5× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-10-28 — shown for context, not personalized investment advice.
KIDS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $621.9M
- P/E (fwd)
- -27.9
- 52-week range
- $14.42–$26.74
- Off 52-week high
- 10.9%
- RSI (14)
- 61
- Volume vs avg
- 1.54×
- Score today
- 5.7/10